Latest News about NVO
Recent news which mentions NVO
Stock Of The Day: Where Will The Eli Lilly Rally End?
December 04, 2024
From Benzinga
From Benzinga
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
December 04, 2024
From Motley Fool
From Benzinga
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
December 03, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
From Benzinga
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
December 02, 2024
From Benzinga
From Benzinga
From Motley Fool
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
November 29, 2024
From Benzinga
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now
November 27, 2024
From Motley Fool
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
From Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
November 25, 2024
From Motley Fool
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
November 18, 2024
From Benzinga
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
November 18, 2024
From Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
November 16, 2024
From Motley Fool
Powell Speaks The Truth - Market Does Not Like It, Consternation About Kennedy, Gaetz, And Hegseth
November 15, 2024
From Benzinga
Amgen Defends Its Investigational Monthly Weight Loss Injection After Analyst Cites MariTide's Impact on Bone Density
November 13, 2024
From Benzinga
What's Going On With Hims & Hers Health Stock On Wednesday?
November 13, 2024
From Benzinga
Humanitarian Organization Criticizes Eli Lilly, Novo Nordisk And Sanofi Of Having 'Double Standards' For High Insulin Price
November 13, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.